

KPV (Lysine-Proline-Valine) is a naturally occurring peptide fragment derived from Alpha-Melanocyte Stimulating Hormone (α-MSH). Unlike α-MSH, KPV retains powerful anti-inflammatory and immune-modulating properties without affecting pigmentation. It has gained significant attention in functional medicine, gut health, autoimmune support, and regenerative medicine due to its ability to help regulate inflammatory pathways throughout the body.
KPV works by helping modulate inflammatory cytokines, reducing excessive immune responses, and supporting healthy gastrointestinal barrier function. Research suggests KPV may help calm chronic inflammation in the digestive tract, skin, and other tissues while promoting healing and restoration of normal cellular function.
KPV is commonly utilized in gut health protocols, inflammatory bowel support programs, autoimmune-focused wellness plans, and skin health regimens. It is often paired with peptides such as BPC-157 for comprehensive gastrointestinal and tissue recovery support.
Clinical Use Cases:
Gut health and intestinal barrier support
Inflammatory bowel support protocols
Leaky gut and gastrointestinal recovery programs
Immune system modulation
Chronic inflammation management
Skin health and inflammatory skin conditions
Autoimmune wellness support
Recovery and regenerative medicine protocols
Adjunct to BPC-157 therapy
Common Protocols:
Typical protocol duration ranges from 4-12 weeks depending on clinical goals and provider recommendations.
Safety & Side Effects:
KPV is generally well tolerated with a favorable safety profile. Possible side effects may include mild injection site irritation, redness, or temporary discomfort. Because KPV works through immune-modulating pathways, patients with complex autoimmune conditions should consult their healthcare provider prior to use. Discontinue use and seek medical advice if adverse reactions occur.
Storage:
Store refrigerated at 36°F-46°F (2°C-8°C). Protect from direct light and excessive heat. Do not freeze. Keep out of reach of children.